» Authors » Hsing-Ju Wu

Hsing-Ju Wu

Explore the profile of Hsing-Ju Wu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 1352
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu T, Yang W, Huang S, Yang W, Wu H, Ho H, et al.
Cancer Cytopathol . 2024 Jul; 132(11):686-695. PMID: 39003588
Background: This study evaluated the diagnostic effectiveness of the AIxURO platform, an artificial intelligence-based tool, to support urine cytology for bladder cancer management, which typically requires experienced cytopathologists and substantial...
2.
Liu K, Yang Y, Hwang K, Wu H
Pathogens . 2023 May; 12(5). PMID: 37242357
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 had reported over 676 million cases by March 2023. The main aim of this study is to investigate whether the levels...
3.
Chang Y, Wu M, Wu H, Liao P, Cheng-Chung Wei J
Pediatr Allergy Immunol . 2023 May; 34(5):e13959. PMID: 37232285
Background: Atopic dermatitis (AD) contributes to substantial social and financial costs in public health care systems. Antibiotic exposure during pregnancy has been proposed as a risk factor, but findings remain...
4.
Nie L, Wang Y, Hsu J, Hou J, Chu Y, Chan L, et al.
Am J Cancer Res . 2023 May; 13(4):1209-1239. PMID: 37168336
Nuclear epidermal growth factor receptor (EGFR) has been shown to be correlated with drug resistance and a poor prognosis in patients with cancer. Previously, we have identified a tripartite nuclear...
5.
Lin H, Wu H, Chu P
J Transl Med . 2023 Mar; 21(1):189. PMID: 36899366
Background: The inner membrane mitochondrial protein (IMMT) is a central unit of the mitochondrial contact site and cristae organizing system (MICOS). While researchers continue to demonstrate the physiological function of...
6.
Liao P, Chu P, Tan Z, Hsu F, Lee Y, Wu H
Anticancer Res . 2022 Jul; 42(8):3807-3814. PMID: 35896246
Background/aim: Breast cancer (BC) is the most common cancer and second leading cause of death in women worldwide. Triple-negative breast cancer (TNBC) is the most aggressive type of BC, while...
7.
Lin Y, Wu H, Van Hieu N, Chu P, Do T, Yao F, et al.
Biosensors (Basel) . 2022 Jul; 12(8). PMID: 35892458
The label-free biosensor has emerged as an effective tool for the purpose of early detection of causative pathogens such as as a preventive measure. In this study, a biorecognition-element-free interdigitated...
8.
Wu H, Chu P
Cancers (Basel) . 2022 May; 14(9). PMID: 35565189
Breast cancer is the most commonly diagnosed cancer and leading cause of cancer mortality among woman worldwide. The techniques of diagnosis, prognosis, and therapy monitoring of breast cancer are critical....
9.
Chang K, Wu H, Liu C, Li C, Lin H
Int J Mol Sci . 2022 Feb; 23(4). PMID: 35216393
The early diagnosis, prognostic prediction, and personalized therapy of lung adenocarcinoma (LUAD) remains a challenging issue. (potassium voltage-gated channel subfamily Q Member 1) is implicated in long QT syndrome (LQTS)...
10.
Lin H, Wu H, Chen S, Hou M, Lin C, Chu P
Biomed Pharmacother . 2021 Nov; 145:112431. PMID: 34798471
Background: There is currently a growing interest in the roles of epigenetic mechanisms in the diagnosis, prognosis, and therapies associated with precision oncology for breast cancer (BC). This study aimed...